What did @iamcynthiagarcia actually say?
Garcia presented GHK-Cu as the one peptide "you can actually see working when you look in the mirror," describing it as something your body makes naturally but loses with age. She said it "literally switches on the genes for cell regeneration," backed by "40 years of research." She uses it two ways: topically for tone and texture, and via injection for "deeper cellular" effects. Her signature tip is using it before and after microneedling or lasers to speed healing. She closed by offering followers access to her sourcing list in exchange for a comment.
Worth noting: she consistently called it "GHQ CEO" throughout the video, which is a mispronunciation of GHK-Cu (glycine-histidine-lysine copper). Small thing, but if you're recommending injections, getting the name right matters.
Does the science back this up?
More than you might expect for an Instagram peptide recommendation, yes. The foundational research is real, though the injectable claims are less supported than the topical ones.
GHK-Cu was first isolated by Loren Pickart in 1973, which is where the "40 years of research" claim comes from. Pickart and colleagues published extensively on its role in wound healing, collagen synthesis, and skin remodeling. A 2015 review by Pickart and Margolina in The Scientific World Journal documented GHK-Cu's ability to upregulate genes involved in collagen production and tissue repair, including activating TGF-beta pathways. That part checks out.
The gene activation claim also has real backing. A 2012 study by Pickart, Vasquez-Soltero, and Margolina in Organogenesis showed GHK-Cu modulates expression of over 4,000 genes in human fibroblasts, including those tied to anti-inflammatory pathways. Calling this "switching on genes for cell regeneration" is a simplification, but it is not wrong.
Topical efficacy for fine lines and skin texture is supported by several controlled studies. Finkley et al. (2007, Journal of Cosmetic Dermatology) found significant improvement in skin laxity and appearance with topical GHK-Cu vs. placebo over 12 weeks. The periprocedural use case, applying it before and after laser or microneedling, has reasonable mechanistic support given its wound-healing properties, though dedicated clinical trials on this specific protocol are limited.
The injectable use is where the evidence gets thin. Human clinical trial data on injected GHK-Cu for aesthetic purposes is sparse. Most injection data comes from wound-healing contexts, not cosmetic optimization.
What did they get wrong (or right)?
Garcia got the topical case largely right. The collagen and inflammation claims are supported by peer-reviewed literature. Credit where it is due.
What she overstated is the injectable angle. Saying injection reaches "a deeper cellular place that a serum just can't reach" sounds compelling, but there are no robust human RCTs confirming that injected GHK-Cu produces meaningfully better aesthetic outcomes than well-formulated topical products. The bioavailability argument is plausible in theory but unproven in practice for cosmetic endpoints.
The sourcing concern is the biggest red flag here. Offering followers a direct link to where she personally sources injectable peptides is not a neutral act. Compounded and gray-market peptide injectables vary wildly in purity and sterility. Without FDA oversight on those specific products, users have no reliable way to verify what is actually in the vial. Recommending injection protocols for a general Instagram audience, without individualized medical supervision, creates real safety exposure. That part deserves a hard pass regardless of how good the underlying peptide science is.
What should you actually know?
GHK-Cu is one of the better-studied cosmetic peptides, and the topical use case is on solid ground relative to most things promoted on wellness Instagram. If you are interested in it, a reputable topical product from a company that publishes its formulation and third-party testing is a reasonable starting point.
The periprocedural tip, using it around microneedling or laser, is mechanistically plausible and low-risk when applied topically. Some dermatology practices already incorporate GHK-Cu into post-procedure protocols for this reason. If you want to try this, talk to the provider doing the procedure.
Injectable GHK-Cu is a different conversation entirely. Injections require sterile compounding, proper dosing, and a provider who can manage adverse events. Sourcing from a list promoted on Instagram, no matter how well-intentioned the creator is, does not meet that bar. Peptide injections obtained outside a licensed medical provider relationship sit in a regulatory gray zone that carries real risk. Do not take that route based on a social media recommendation.
The broader research on GHK-Cu in longevity contexts, including its apparent effects on oxidative stress and inflammation markers, is genuinely interesting. But interesting early research is not the same as clinical evidence of benefit in healthy people using injections for anti-aging purposes.